We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Dr. Daniel Vitt joined Immunic from 4SC AG, a publicly listed stock
company based in Martinsried, Germany, which he co-founded in 1997. At 4SC, he served as CSO and CDO. In this position, he transformed 4SC from a research company into an advanced therapeutic development company and brought the company public on German stock exchange in Frankfurt in 2005.
Daniel Vitt studied chemistry in Siegen and Würzburg, Germany, from 1989-1994 and graduated at the University of Würzburg in quantum-chemical calculations of organic reactions. During his Ph.D. studies, he focused on molecular design of small molecule therapeutics. In 1998, he received his Ph.D. from the Institute of organic chemistry at the University of Würzburg.
This speaker's sessions: